Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.

Saved in:
Bibliographic Details
Title: Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Authors: Radue EW; Medical Image Analysis Center, University Hospital Basel, Schanzenstrasse 55, 1st Floor, CH 4031, Basel, Switzerland. eradue@uhbs.ch, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW
Corporate Authors: SENTINEL Investigators
Source: Journal of the neurological sciences [J Neurol Sci] 2010 May 15; Vol. 292 (1-2), pp. 28-35. Date of Electronic Publication: 2010 Mar 16.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5883 (Electronic) Linking ISSN: 0022510X NLM ISO Abbreviation: J Neurol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-5883
DOI:10.1016/j.jns.2010.02.012